Trial Profile
The Association of Iodixanol (Visipaque) to Renal Function and Cardiac and Cerebrovascular Events in STEMI Patients Undergoing Primary PCI: A Prospective, Multi-National, Multi-Center, Open-Label, Observational Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2021
Price :
$35
*
At a glance
- Drugs Iodixanol (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Sponsors GE Healthcare
- 29 Jun 2021 Status changed from recruiting to completed.
- 21 Jul 2020 Planned End Date changed from 1 Jun 2020 to 1 Dec 2020.
- 21 Jul 2020 Planned primary completion date changed from 1 Jun 2020 to 1 Dec 2020.